Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Utility of uroplakin II expression as a marker of urothelial carcinoma.

Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ.

Hum Pathol. 2015 Jan;46(1):58-64. doi: 10.1016/j.humpath.2014.09.007. Epub 2014 Oct 2.

PMID:
25449628
[PubMed - in process]
2.

MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers.

Mohseni M, Cidado J, Croessmann S, Cravero K, Cimino-Mathews A, Wong HY, Scharpf R, Zabransky DJ, Abukhdeir AM, Garay JP, Wang GM, Beaver JA, Cochran RL, Blair BG, Rosen DM, Erlanger B, Argani P, Hurley PJ, Lauring J, Park BH.

Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17606-11. doi: 10.1073/pnas.1408650111. Epub 2014 Nov 24.

PMID:
25422431
[PubMed - in process]
3.

Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases.

Poling JS, Tsangaris TN, Argani P, Cimino-Mathews A.

Breast Cancer Res Treat. 2014 Nov;148(2):355-61. doi: 10.1007/s10549-014-3161-x. Epub 2014 Oct 16.

PMID:
25318925
[PubMed - in process]
4.

A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.

Cimino-Mathews A, Sharma R, Illei PB, Vang R, Argani P.

Am J Surg Pathol. 2014 Dec;38(12):1689-96. doi: 10.1097/PAS.0000000000000301.

PMID:
25046342
[PubMed - indexed for MEDLINE]
5.

NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.

Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong AP, Sharma R, Illei PB, Argani P, Cimino-Mathews A.

J Clin Pathol. 2014 Sep;67(9):768-71.

PMID:
24996432
[PubMed - indexed for MEDLINE]
6.

A subset of nondescript axillary lymph node inclusions have the immunophenotype of endosalpingiosis.

Carney E, Cimino-Mathews A, Argani C, Kronz J, Vang R, Argani P.

Am J Surg Pathol. 2014 Dec;38(12):1612-7. doi: 10.1097/PAS.0000000000000261.

PMID:
24921637
[PubMed - indexed for MEDLINE]
7.

Detection of cancer DNA in plasma of patients with early-stage breast cancer.

Beaver JA, Jelovac D, Balukrishna S, Cochran RL, Croessmann S, Zabransky DJ, Wong HY, Valda Toro P, Cidado J, Blair BG, Chu D, Burns T, Higgins MJ, Stearns V, Jacobs L, Habibi M, Lange J, Hurley PJ, Lauring J, VanDenBerg DA, Kessler J, Jeter S, Samuels ML, Maar D, Cope L, Cimino-Mathews A, Argani P, Wolff AC, Park BH.

Clin Cancer Res. 2014 May 15;20(10):2643-50. doi: 10.1158/1078-0432.CCR-13-2933. Epub 2014 Feb 6.

PMID:
24504125
[PubMed - in process]
8.

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers.

Jelovac D, Beaver JA, Balukrishna S, Wong HY, Toro PV, Cimino-Mathews A, Argani P, Stearns V, Jacobs L, VanDenBerg D, Kessler J, Jeter S, Park BH, Wolff AC.

Hum Pathol. 2014 Apr;45(4):880-3. doi: 10.1016/j.humpath.2013.10.016. Epub 2013 Oct 31.

PMID:
24444464
[PubMed - indexed for MEDLINE]
9.

GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.

Ellis CL, Chang AG, Cimino-Mathews A, Argani P, Youssef RF, Kapur P, Montgomery EA, Epstein JI.

Am J Surg Pathol. 2013 Nov;37(11):1756-60. doi: 10.1097/PAS.0b013e31829cdba7.

PMID:
24061521
[PubMed - indexed for MEDLINE]
10.

Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype.

VandenBussche CJ, Elwood H, Cimino-Mathews A, Bittar Z, Illei PB, Warzecha HN.

Hum Pathol. 2013 Nov;44(11):2487-93. doi: 10.1016/j.humpath.2013.06.007. Epub 2013 Sep 10.

PMID:
24029706
[PubMed - indexed for MEDLINE]
11.

A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.

Cimino-Mathews A, Hicks JL, Sharma R, Vang R, Illei PB, De Marzo A, Emens LA, Argani P.

Hum Pathol. 2013 Nov;44(11):2494-500. doi: 10.1016/j.humpath.2013.06.009. Epub 2013 Jul 31.

PMID:
23916291
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERĪ± and inducing IL-6 expression.

Shah N, Jin K, Cruz LA, Park S, Sadik H, Cho S, Goswami CP, Nakshatri H, Gupta R, Chang HY, Zhang Z, Cimino-Mathews A, Cope L, Umbricht C, Sukumar S.

Cancer Res. 2013 Sep 1;73(17):5449-58. doi: 10.1158/0008-5472.CAN-13-1178. Epub 2013 Jul 5.

PMID:
23832664
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.

Cimino-Mathews A, Ye X, Meeker A, Argani P, Emens LA.

Hum Pathol. 2013 Oct;44(10):2055-63. doi: 10.1016/j.humpath.2013.03.010. Epub 2013 May 21.

PMID:
23701942
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.

Vandenbussche CJ, Khouri N, Sbaity E, Tsangaris TN, Vang R, Tatsas A, Cimino-Mathews A, Argani P.

Am J Surg Pathol. 2013 Jun;37(6):913-23. doi: 10.1097/PAS.0b013e31828ba25c.

PMID:
23598968
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.

Bozeman EN, Cimino-Mathews A, Machiah DK, Patel JM, Krishnamoorthy A, Tien L, Shashidharamurthy R, Selvaraj P.

Vaccine. 2013 May 7;31(20):2449-56. doi: 10.1016/j.vaccine.2013.03.028. Epub 2013 Mar 28.

PMID:
23541884
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.

Moore HM, Gonzalez ME, Toy KA, Cimino-Mathews A, Argani P, Kleer CG.

Breast Cancer Res Treat. 2013 Apr;138(3):741-52. doi: 10.1007/s10549-013-2498-x. Epub 2013 Mar 29.

PMID:
23539298
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

SP3, a reliable alternative to HercepTest in determining HER-2/neu status in breast cancer patients.

D'Alfonso TM, Liu YF, Chen Z, Chen YB, Cimino-Mathews A, Shin SJ.

J Clin Pathol. 2013 May;66(5):409-14. doi: 10.1136/jclinpath-2012-201270. Epub 2013 Feb 5.

PMID:
23386665
[PubMed - indexed for MEDLINE]
18.

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.

Cimino-Mathews A, Subhawong AP, Illei PB, Sharma R, Halushka MK, Vang R, Fetting JH, Park BH, Argani P.

Hum Pathol. 2013 Jul;44(7):1341-9. doi: 10.1016/j.humpath.2012.11.003. Epub 2013 Jan 31.

PMID:
23375642
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.

Cimino-Mathews A, Subhawong AP, Elwood H, Warzecha HN, Sharma R, Park BH, Taube JM, Illei PB, Argani P.

Hum Pathol. 2013 Jun;44(6):959-65. doi: 10.1016/j.humpath.2012.09.005. Epub 2012 Dec 20.

PMID:
23260325
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.

Santa-Maria CA, Cimino-Mathews A, Moseley KF, Wolff AC, Blakeley JO, Connolly RM.

Clin Breast Cancer. 2012 Dec;12(6):445-9. doi: 10.1016/j.clbc.2012.07.010. Epub 2012 Sep 24. No abstract available.

PMID:
23010203
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk